BioNexus Gene Lab Corp (NASDAQ:BGLC) does about 622.40K shares in volume on a normal day but saw 50360527 shares change hands in the recent trading day. The company now has a market cap of 20.01M USD. Its current market price is $11.14, marking an increase of 262.87% compared to the previous close of $3.07. The 52 week high reached by this stock is $8.40 whilst the lowest price level in 52 weeks is $2.01.
BioNexus Gene Lab Corp (BGLC) has a 20-day trading average at $3.36 and the current price is 32.62% off the 52-week high compared with 455.11% distance from its 52-week low. The 50-day simple moving average of the closing price is $3.13 and its 200-day simple moving average is $3.33. If we look at the stock’s price movements over the week, volatility stands at 23.77%, which decreases to 13.26% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 90.75 to suggest the stock is overbought.
The current price level is 231.14%, 255.66%, and 234.06% away from its SMA20, SMA50, and SMA200 respectively, with the BGLC price moving below the 50-day SMA on current market day. BioNexus Gene Lab Corp (BGLC) stock is up 317.23% over the week and 159.67% over the past month. Its price is 141.65% year-to-date and 298.28% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at 0 and 0 for whole year.
Outstanding shares total 1.80M with insiders holding 51.11% of the shares and institutional holders owning 0.88% of the company’s common stock. The company has a return on investment of -26.74% and return on equity of -24.75%. The beta has a value of 1.80. Price to book ratio is 2.58 and price to sales ratio is 2.16.
